Equity Research, Broker Reports, and media content on BASILEA PHARMACEUTICA-REG

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about BASILEA PHARMACEUTICA-REG
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on BASILEA PHARMACEUTICA-REG. We currently have 4 research reports from 1 professional analysts.

Open
76.5
Volume
0.1m
Range
75.7/78.3
Market Cap
917,330,406m
52 Week
61.2/84.7
Date Source Announcement
20Feb17 06:15 GNW Basilea reports solid 2016 results and expects to double product sales in 2017
29Dec16 06:15 GNW Basilea names new member of its Extended Management Committee
02Dec16 06:15 GNW Basilea expands oncology drug candidate BAL101553 clinical phase 1/2a oral study to include glioblastoma patients
15Nov16 06:15 GNW Basilea's antifungal Cresemba® (isavuconazole) launched in France
20Sep16 06:15 GNW Basilea announces distribution agreement with Unimedic for CRESEMBA® (isavuconazole) and Zevtera® (ceftobiprole) in the Nordic countries
15Sep16 06:15 GNW Basilea announces partnership for antifungal isavuconazole in Japan with Asahi Kasei Pharma
13Sep16 06:15 GNW Basilea announces supply, distribution and license agreement with Grupo Biotoscana for CRESEMBA® (isavuconazole) and Zevtera® (ceftobiprole) in Latin America
  • Frequency of research reports

     

  • Research reports on

    BASILEA PHARMACEUTICA-REG

  • Providers covering

    BASILEA PHARMACEUTICA-REG

Latest Content

View the latest research, videos, and podcasts for this company.